HealthTide Biotech
Ordered peptides from HealthTide Biotech? Mail in a sample (US only) and let us test it.
Test my supplyHealthTide Biotech's purity-focus record is strongest in GHK-Cu and Retatrutide, where identity and purity generally pass, but fill and traceability keep the evidence from looking uniform. Tirzepatide is more dispersed, with early low-purity failures followed by cleaner near-fill results, while GHK-Cu has a major underfill and many entries lack batch IDs.
Archived B2B records tie HealthTide’s sales email domain to a Hong Kong-linked CONTIDE identity that later disappeared from ChemicalBook. The report also traces a parked storefront, US WhatsApp channel, and Texas-facing near-name reseller.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including HealthTide Biotech rows.
Cancel anytime
Ordered peptides from HealthTide Biotech? Mail in a sample (US only) and let us test it.
Test my supply| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
25 Aug 2026 | Pass | GHK-Cu HealthTide Biotech | lab name | View COA | |||
9 Aug 2026 | Pass | Tirzepatide HealthTide Biotech | lab name | View COA | |||
20 Jul 2026 | Fail | Retatrutide HealthTide Biotech | lab name | View COA | |||
26 Feb 2026 | Pass | Retatrutide HealthTide Biotech | lab name | View COA | |||
26 Feb 2026 | Fail | GHK-Cu HealthTide Biotech | lab name | View COA | |||
26 Feb 2026 | Pass | Tirzepatide HealthTide Biotech | lab name | View COA | |||
22 Feb 2026 | Pass | Retatrutide HealthTide Biotech | lab name | View COA | |||
2 Feb 2026 | Pass | GHK-Cu HealthTide Biotech | lab name | View COA | |||
15 Jan 2026 | Pass | Retatrutide HealthTide Biotech | lab name | View COA | |||
15 Jan 2026 | Pass | GHK-Cu HealthTide Biotech | lab name | View COA | |||
About HealthTide Biotech test results from Finnrick
HealthTide Biotech is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 18 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible HealthTide Biotech peptides in this dataset are GHK-Cu (5 tests), Retatrutide (6 tests) and Tirzepatide (7 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 18 recent tests.
Ordered peptides from HealthTide Biotech? Mail in a sample (US only) and let us test it.
Test my supply